Outlook Therapeutics's total assets for Q1 2025 were $17.01M, a decrease of -41.00% from the previous quarter. OTLK total liabilities were $67.30M for the fiscal quarter, a -33.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.